Literature DB >> 26836913

Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis.

Amélie Seguin1, Lionel Galicier1, David Boutboul1, Virginie Lemiale1, Elie Azoulay2.   

Abstract

BACKGROUND: Acquired hemophagocytic lymphohistiocytosis (HLH) is a life-threatening event that usually occurs as a complication of immunodeficiency. Lung involvement in HLH has received little attention. This article describes lung involvement in HLH and assesses whether it affects the prognosis.
METHODS: We retrospectively studied 219 patients with HLH admitted to a national reference center over a 14-year period, including 118 (54%) with lung involvement.
RESULTS: Dyspnea and cough were the most common onset symptoms. Radiographs revealed interstitial infiltrates with centrilobular nodules, ill-defined consolidation, or localized ground-glass opacities. Pleural effusions and mediastinal lymphadenopathies were found in approximately one-half of the patients. One or more causes of lung involvement were documented in 91 of 118 patients (77.1%) and included infection (n = 52), pulmonary edema (n = 34), and malignancies (n = 22 [mostly lymphoma]). HLH-specific treatment combined with treatment of the cause of lung involvement improved respiratory function in only 67 of the 188 patients (56.7%). Hospital mortality was higher in patients with lung involvement (52.5% vs 20%). Infection as the cause of lung involvement was the only determinant of death (56% vs 30%; P = .004).
CONCLUSIONS: Lung involvement is common and of poor prognosis in patients with HLH. Studies should assess whether specific diagnostic and therapeutic strategies are warranted in patients with HLH and lung involvement.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; acute respiratory failure; hematologic malignancies; hemophago-cytosis; hemophagocytic lymphohistiocytosis; lung involvement

Mesh:

Year:  2016        PMID: 26836913     DOI: 10.1016/j.chest.2015.11.004

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  51 in total

Review 1.  Haemophagocytic lymphohistiocytosis in pregnancy.

Authors:  Harold Wilson-Morkeh; Charlotte Frise; Taryn Youngstein
Journal:  Obstet Med       Date:  2021-09-26

2.  Intrathoracic infections in Hodgkin lymphoma (HL) patients may cooperate with HL to trigger hemophagocytic lymphohistiocytosis: A retrospective study.

Authors:  Ji-Cheng Zhou; Bin-Bin Tan; Yan Huang; Yin-Ying Wu; Zhen-Jie Bai; Min-Lan Liang; Wei-Hua Zhao
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

3.  Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.

Authors:  Piero Ruscitti; Ilenia Di Cola; Onorina Berardicurti; Alessandro Conforti; Daniela Iacono; Ilenia Pantano; Gelsomina Rozza; Silvia Rossi; Ludovico De Stefano; Silvia Balduzzi; Antonio Vitale; Francesco Caso; Luisa Costa; Marcella Prete; Luca Navarini; Fabiola Atzeni; Giuliana Guggino; Federico Perosa; Luca Cantarini; Bruno Frediani; Carlomaurizio Montecucco; Francesco Ciccia; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Rheumatol       Date:  2021-10-11       Impact factor: 3.650

Review 4.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

5.  Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.

Authors:  Dewald Schoeman; Burtram C Fielding
Journal:  mSphere       Date:  2021-05-12       Impact factor: 4.389

6.  Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Authors:  Giovanni Caocci; Giorgio La Nasa
Journal:  Ann Hematol       Date:  2020-05-14       Impact factor: 3.673

7.  Acute fibrinous and organizing pneumonia following hemophagocytic syndrome in two adult patients with hematological malignancies.

Authors:  Satoru Nanno; Hideo Koh; Hiroshi Okamura; Mitsutaka Nishimoto; Yasuhiro Nakashima; Masahiko Ohsawa; Masayuki Hino; Hirohisa Nakamae
Journal:  J Clin Exp Hematop       Date:  2021-04-20

8.  Secondary Hemophagocytic Lymphohistiocytosis Complicated by a Cavitary Lung Lesion in a Kidney Transplant Recipient.

Authors:  Katarzyna Muras-Szwedziak; Maciej Tylski; Anna Masajtis-Zagajewska; Michał Nowicki
Journal:  Case Rep Nephrol Dial       Date:  2021-07-09

Review 9.  Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.

Authors:  Gunawan Widjaja; Abduladheem Turki Jalil; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Dmitry O Bokov; Wanich Suksatan; Mahnaz Ghaebi; Faroogh Marofi; Jamshid Gholizadeh Navashenaq; Farhad Jadidi-Niaragh; Majid Ahmadi
Journal:  Hum Immunol       Date:  2021-07-01       Impact factor: 2.850

10.  Repurposing of Mycobacterium indicus pranii for the severe form of COVID-19 patients in India: A cohort study.

Authors:  Naveed Nazir Shah; Khurshid Ahmad Dar; Syed Quibtiya; Aaliya Mohi Ud Din Azad; Mehvish Mushtaq; Showkeen Muzamil Bashir; Muzafar Ahmad Rather; Sofi Imtiyaz Ali; Wajid Mohammad Sheikh; Showkat Ul Nabi
Journal:  J Med Virol       Date:  2022-01-07       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.